FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter study

scientific article published on 27 August 2009

FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1399-0012.2009.01070.X
P698PubMed publication ID19719728

P50authorHans SollingerQ89951480
P2093author name stringR Shapiro
B D Kahan
P R Rajagopalan
M I Lorber
H Mayer
C E Foster
D B Carvalho
FTY720A2202 clinical study group
H Tedesco-Silva
J Slade
R Mendez
P2860cites workCell type-specific localization of human cardiac S1P receptorsQ28215436
Early, abrupt conversion of de novo renal transplant patients from cyclosporine to everolimus: results of a pilot studyQ46750522
FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory.Q52026935
P433issue5
P921main subjectmulticenter clinical trialQ6934595
P304page(s)589-599
P577publication date2009-08-27
P1433published inClinical TransplantationQ15754920
P1476titleFTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter study
P478volume23

Reverse relations

cites work (P2860)
Q35953902A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia.
Q36861092Effect of FTY720 (fingolimod) on graft survival in renal transplant recipients: a systematic review protocol.
Q83973683Effects of long-term administration of low-dose FTY720 on survival of murine cardiac allograft
Q37945385Fifty years in the vineyard of transplantation: looking back
Q26785848Lymphatic disorders after renal transplantation: new insights for an old complication
Q21296721Sphingolipids: a potential molecular approach to treat allergic inflammation
Q37813491Sphingosine-1-phosphate: a potential therapeutic target for rheumatoid arthritis
Q37888772The emerging role of Brazil in clinical trial conduct for transplantation
Q84744062The sphingosine-1-phosphate receptor agonist FTY720 prevents the development of anti-glomerular basement membrane glomerulonephritis

Search more.